Ticker Scorecard - DNLI Basics Company: Denali Therapeutics Inc. IPO Date: December 8, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.14B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.74% Avg Daily Range (30 D): $0.61 | 2.89% Avg Daily Range (90 D): $0.58 | 2.36% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .76M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 2,868 Avg Inst. Trade: $2.81M Avg Inst. Trade (30 D): $3.01M Avg Inst. Trade (90 D): $3.32M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.83M Avg Closing Trade (30 D): $4.01M Avg Closing Trade (90 D): $3.68M Avg Closing Volume: 128.02K     News Aug 1, 2024 @ 4:25 PM Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guida... Source: Zacks Equity Research Jul 4, 2024 @ 1:40 AM Denali Therapeutics director sells over $678k in c... Source: Investing.Com Jun 28, 2024 @ 12:37 PM Denali (DNLI) Outperforms Industry in 3 Months: He... Source: Zacks Equity Research Jun 24, 2024 @ 1:07 PM Denali Therapeutics (DNLI) Moves 5.8% Higher: Will... Source: Zacks Equity Research Jun 7, 2024 @ 3:30 PM Why Is Prothena (PRTA) Down 1.5% Since Last Earnin... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.76 $-.63 $-.59 Diluted EPS $-2.76 $-.63 $-.59 Revenue $ 14.54M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -427.49M $ -107.19M $ -99.03M Operating Income / Loss $ -490.07M $ -123.19M $ -116.59M Cost of Revenue $ $ $ Net Cash Flow $ -57.38M $ 15.96M $ 14.11M PE Ratio